People In The News: Tracking The Latest Industry Personnel Moves
Executive Summary
Presidents and CEOs
You may also be interested in...
PanGenetics "Experiment" Winding Down, CEO Kevin Johnson to Pursue Asset-Centric Model at Index Ventures
The Belgian biotech secured an exit for investors with last year's unusual front-end loaded NGF deal with Abbott, but lightning won't strike twice as its second program can't get through Phase I.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.